Marker Therapeutics, Inc. (MRKR) vs Palatin Technologies, Inc. (PTN)
A side-by-side comparison of Marker Therapeutics, Inc. and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MRKR
Marker Therapeutics, Inc.
$1.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PTN
Palatin Technologies, Inc.
$9.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MRKR vs PTN
growth of $100 · dividends reinvested · last 10yMRKR -98.2% (-33.2%/yr)PTN -98.7% (-35.1%/yr)MRKR compounded faster over this window
MRKR PTN
MRKR vs PTN: by the numbers
- •MRKR is the larger company ($17M vs $17M market cap).
- •Both run net losses; PTN's is the smaller (-63.54% vs -706.23% net margin).
Metrics side by side
Valuation
| Metric | MRKR | PTN |
|---|---|---|
| P/S ratio | 13.66 | 1.27 |
| P/B ratio | 1.38 | 2.50 |
Profitability
| Metric | MRKR | PTN |
|---|---|---|
| Gross margin | 0.00% | 99.63% |
| Operating margin | 0.00% | -65.74% |
| Net margin | -706.23% | -63.54% |
| ROE | -71.57% | -125.30% |
| ROIC | -88.07% | -125.44% |
Growth (annualized)
| Metric | MRKR | PTN |
|---|---|---|
| Total return CAGR (5Y) | -42.13% | -55.41% |
Frequently asked
- How have MRKR and PTN total returns compared?
- Over the past 10 years, MRKR delivered -33.25% and PTN delivered -35.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.